June 11, 2025 – Framatome announces the acquisition of a 40% stake in Selectarc, alongside its majority stakeholder, Viellard Migeon & Compagnie.

This partnership will secure the supply of strategic filler metals, essential in the manufacturing of components of the primary circuit of the French nuclear reactors.